News
Pfizer's Tukysa greenlit for earlier use in breast cancer
Pfizer gets FDA approval for maintenance use of its oral HER2 inhibitor Tukysa in breast cancer, which it hopes will unlock renewed sales growth.
News
PhRMA sues Trump administration over GLOBE rebate scheme
PhRMA is challenging the Trump administration's GLOBE model for Most-Favoured Nation pricing in Medicare Part B in a US district court.
News
Rhapsido is first drug cleared for chronic hives disorder SD
Novartis' oral BTK inhibitor Rhapsido has had its label expanded in the US to include a second indication that causes chronic hives.
News
MSD ordered to pull injectable Keytruda from sale in Europe
MSD has been rocked by a court judgment ordering it to stop making and selling subcutaneous Keytruda in eight European markets.
News
UK watchdog takes first action on oral weight drug adverts
Online pharmacies operating in the UK breached Advertising Standards Authority rules by promoting oral weight drugs to the public.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
